|
1
|
Stewart AJ, Westley BR and May FE:
Modulation of the proliferative response of breast cancer cells to
growth factors by oestrogen. Br J Cancer. 66:640–648. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Santen RJ, Fan P, Zhang Z, Bao Y, Song RX
and Yue W: Estrogen signals via an extra-nuclear pathway involving
IGF-1R and EGFR in tamoxifen-sensitive and -resistant breast cancer
cells. Steroids. 74:586–594. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yamashita H: Current research topics in
endocrine therapy for breast cancer. Int J Clin Oncol. 13:380–383.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hopp TA, Weiss HL, Parra IS, Cui Y,
Osborne CK and Fuqua SA: Low levels of estrogen receptor beta
protein predict resistance to tamoxifen therapy in breast cancer.
Clin Cancer Res. 10:7490–7499. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gonzalez-Angulo AM, Morales-Vasquez F and
Hortobagyi GN: Overview of resistance to systemic therapy in
patients with breast cancer. Adv Exp Med Biol. 608:1–22. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bos R, van Diest PJ, van der Groep P,
Shvarts A, Greijer AE and van der Wall E: Expression of
hypoxia-inducible factor-1alpha and cell cycle proteins in invasive
breast cancer are estrogen receptor related. Breast Cancer Res.
6:R450–R459. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nolan MK, Jankowska L, Prisco M, Xu S,
Guvakova MA and Surmacz E: Differential roles of IRS-1 and SHC
signaling pathways in breast cancer cells. Int J Cancer.
72:828–834. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Surmacz E: Function of the IGF-I receptor
in breast cancer. J Mammary Gland Biol Neoplasia. 5:95–105. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Koda M, Sulkowski S, Kanczuga-Koda L,
Surmacz E and Sulkowska M: Expression of ERα, ERβ and Ki-67 in
primary tumors and lymph node metastases in breast cancer. Oncol
Rep. 11:753–759. 2004.
|
|
10
|
Koda M, Sulkowska M, Kanczuga-Koda L and
Sulkowski S: Expression of insulin receptor substrate 1 in primary
breast cancer and lymph node metastases. J Clin Pathol. 58:645–649.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Koda M, Kanczuga-Koda L, Reszec J,
Sulkowska M, Famulski W, Baltaziak M, Kisielewski W and Sulkowski
S: Expression of the apoptotic markers in normal breast epithelium,
benign mammary dysplasia and in breast cancer. Folia Morphol.
63:337–341. 2004.PubMed/NCBI
|
|
12
|
Garofalo C, Koda M, Cascio S, Sulkowska M,
Kanczuga-Koda L, Golaszewska J, Russo A, Sulkowski S and Surmacz E:
Increased expression of leptin and the leptin receptor as a marker
of breast cancer progression: possible role of obesity-related
stimuli. Clin Cancer Res. 12:1447–1453. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Redondo M, Garcia J, Rodrigo I, Villar E,
González C and Morell M: Expression of bax and p53 proteins in the
tumorigenesis and progression of breast carcinomas. Tumor Biol.
24:23–31. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Arun B, Kilic G, Yen C, Foster B, Yardley
D, Gaynor R and Ashfaq R: Correlation of Bcl-2 and p53 expression
in primary breast tumors and corresponding metastatic lymph nodes.
Cancer. 98:2554–2559. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Koda M, Lenczewski A, Sulkowska M,
Kanczuga-Koda L, Wincewicz A, Tomaszewski J and Sulkowski S: The
effect of chemotherapy on status of estrogen receptors in primary
tumors and lymph node metastases of human ductal breast cancer.
Oncol Rep. 17:385–391. 2007.PubMed/NCBI
|
|
16
|
Koda M, Sulkowska M, Kanczuga-Koda L,
Tomaszewski J, Kucharczuk W, Lesniewicz T, Cymek S and Sulkowski S:
The effect of chemotherapy on Ki-67, Bcl-2 and Bak expression in
primary tumors and lymph node metastases of breast cancer. Oncol
Rep. 18:113–119. 2007.PubMed/NCBI
|
|
17
|
Koda M, Sulkowski S, Garofalo C,
Kańczuga-Koda L, Sulkowska M and Surmacz E: Expression of the
insulin-like growth factor-I receptor in primary breast cancer and
lymph node metastases: correlations with estrogen receptors α and
β. Horm Metab Res. 35:794–801. 2003.PubMed/NCBI
|
|
18
|
Koda M, Przystupa W, Jarzabek K, Wincewicz
A, Kanczuga-Koda L, Tomaszewski J, Sulkowska M, Wolczynski S and
Sulkowski S: Expression of insulin-like growth factor-I receptor,
estrogen receptor α, Bcl-2 and Bax proteins in human breast cancer.
Oncol Rep. 14:93–98. 2005.
|
|
19
|
Wu JM, Fackler MJ, Halushka MK, Molavi DW,
Taylor ME, Teo WW, Griffin C, Fetting J, Davidson NE, De Marzo AM,
Hicks JL, Chitale D, Ladanyi M, Sukumar S and Argani P:
Heterogeneity of breast cancer metastases: comparison of
therapeutic target expression and promoter methylation between
primary tumors and their multifocal metastases. Clin Cancer Res.
14:1938–1946. 2008. View Article : Google Scholar
|
|
20
|
Rochaix P, Krajewski S, Reed JC, Bonnet F,
Voigt JJ and Brousset P: In vivo patterns of Bcl-2 family protein
expression in breast carcinomas in relation to apoptosis. J Pathol.
187:410–415. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ferrieres G, Cuny M, Simony-Lafontaine J,
Jacquemier J, Rouleau C, Guilleux F, Grenier J, Rouanet P, Pujol H,
Jeanteur P and Escot C: Variation of bcl-2 expression in breast
ducts and lobules in relation to plasma progesterone levels:
overexpression and absence of variation in fibroadenomas. J Pathol.
183:204–211. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Leung LK and Wang TT: Paradoxical
regulation of Bcl-2 family proteins by 17β-oestradiol in human
breast cancer cells MCF-7. Br J Cancer. 81:387–392. 1999.PubMed/NCBI
|
|
23
|
Berardo MD, Elledge RM, de Moor C, Clark
GM, Osborne CK and Allred DC: Bcl-2 and apoptosis in lymph node
positive breast carcinoma. Cancer. 82:1296–1302. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sierra A, Castellsague X, Coll T, Manas S,
Escobedo A, Moreno A and Fabra A: Expression of death-related genes
and their relationship to loss of apoptosis in T1 ductal breast
carcinomas. Int J Cancer. 79:103–110. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gueth U, Huang DJ, Schoetzau A, Holzgreve
W and Wight E: Systemic therapy of metastatic breast cancer: the
truth beyond the clinical trials. Oncology. 76:247–253. 2009.
View Article : Google Scholar : PubMed/NCBI
|
